Project Grant R21AI185527
Award Date
6/11/25
Completion Date
5/31/27
Dollars Obligated
$231K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $210,867 to Drexel University to develop a cell-based therapy for generating donor-specific immune tolerance in kidney transplant recipients. The goal is to engineer potent tolerogenic dendritic cells (toldcs) that can be infused into donor kidneys prior to transplantation. These engineered toldcs will contain...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $612,975.00 to fund research aimed at achieving long-term acceptance of organ transplants without the need for chronic immunosuppression. The research seeks to develop a translational model that combines T-cell costimulation blockade with inhibition of monocyte allorecognition via CD47 to induce long-term graft...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,648,086.00 to The Trustees of the University of Pennsylvania to conduct research on inducing immune tolerance for kidney transplant recipients. The key objective is to use a CD20-targeted CAR T cell therapy to deplete the B cell compartment and allow regeneration of a tolerogenic B cell repertoire in the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $417,984 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Scripps Research Institute in La Jolla, California. The grant, awarded on March 7, 2025, will support research to identify actionable targets for the selective induction of regulatory T cell (Treg) differentiation. The research aims to address a key knowledge gap in understanding the biology and application of naive CD4...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $246,623 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to New York University School of Medicine to conduct research on the molecular control of tolerogenic dendritic cell function. The overarching goal is to delineate the molecular mechanisms underlying the tolerogenic function of dendritic cells and their role in promoting immune tolerance. The 2-year project, spanning November 2024 to...
This federal Project Grant award of $441,202.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to investigate the role of ex-regulatory T cells (ex-Tregs) in autoimmunity and cancer immunity. The research aims to utilize a genetic Treg lineage tracing system to monitor ex-Tregs and test whether they are required for tumor control or the onset of autoimmune disease when...
The University of Pittsburgh received a $679,937 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to conduct research on mechanisms and therapeutic targeting of T cell regulation in heart allograft recipient monkeys. The 5-year project aims to investigate the impact of cytokine modulation and administration of novel, donor-specific chimeric antigen receptor regulatory T cells (CARTREG) on promoting long-term...
This federal Project Grant award of $350,000 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to develop polymer-derived biomaterials for messenger RNA (mRNA) delivery to induce antigen-specific immune tolerance. The award supports research to evaluate diverse nanocarrier formulations encapsulating antigens and mRNAs encoding tolerogenic proteins, investigate the biodistribution and...
This $300,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of a GMP-compliant E. coli dihydrofolate reductase (EDHFR) vector. This vector will be used to monitor the biodistribution and trafficking of investigational chimeric antigen receptor (CAR) T cell therapies through positron emission tomography (PET) imaging. The goals are to provide a...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,286,273 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Trustees of Columbia University in the City of New York to conduct preclinical research on inducing liver transplant tolerance. The key objectives are to develop clinically applicable protocols for tolerance induction in living and deceased donor liver transplantation, and to define the underlying immunological...